Announcements Trials

Browse Landscape

Clinical Trials

0 trials

Recent Start date Enrollment

Liposarcoma × ribociclib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 22 Neoplasm Metastasis 4 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Solid Tumors 1 Prostatic Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Lung Neoplasms 1 Locoregional Recurrence 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 HR+/HER2- Breast Cancer 1 HER2 Negative Breast Cancer Not Immediately Operated 1 Glioma 1 Glioblastoma 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 ER+ HER2- Advanced Breast Cancer 1 Digestive System Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Breast Diseases 1 Brain Neoplasms 1 Astrocytoma 1 Anatomic Stage II Breast Cancer AJCC v8 1 Advanced Breast Cancer 1

Interventions

Specimen Handling 4 Doxorubicin 4 Biopsy 3 pazopanib 2 Radiotherapy 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Ifosfamide 2 toripalimab 1 talimogene laherparepvec 1 silmitasertib 1 selinexor 1 peposertib 1 pembrolizumab 1 liposomal doxorubicin 1 fludarabine phosphate 1 fludarabine 1 eribulin 1 durvalumab 1 abemaciclib 1 X-Rays 1 Vincristine 1 Temozolomide 1 Surgical Procedures, Operative 1 Radiotherapy, Intensity-Modulated 1 Proton Therapy 1 Neoadjuvant Therapy 1 Irinotecan 1 Immunoglobulin G 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡